Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion type Assertion NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_head.
- NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion wasGeneratedBy ECO_0000203 NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_provenance.
- NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion wasDerivedFrom befree-20150227 NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_provenance.
- NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion SIO_000772 19673887 NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_provenance.
- NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion evidence source_evidence_literature NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_provenance.
- NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_assertion description "[Restoration of BRAK / CXCL14 gene expression by gefitinib is associated with antitumor efficacy of the drug in head and neck squamous cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826153.RACrEnd_cOtizZMFpUkX4_oS79YNnkXqtObvfFeqRSmL8130_provenance.